Skip to content
healthcare.dev

FLUBLOK TRIVALENT NORTHERN HEMISPHERE

NDC 49281-726, INFLUENZA A VIRUS A/Missouri/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/Darwin/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/Pennsylvania/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN, injection, from Sanofi Vaccines US Inc..

Product NDC
49281-726
Status
Listed
Labeler
Sanofi Vaccines US Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125285
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49281-726 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLUENZA A VIRUS A/MISSOURI/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN45 ug/.5mL
  • INFLUENZA A VIRUS A/DARWIN/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN45 ug/.5mL
  • INFLUENZA B VIRUS B/PENNSYLVANIA/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN45 ug/.5mL
Package NDCNDC-11Package
49281-726-104928107261010 SYRINGE in 1 CARTON (49281-726-10) / .5 mL in 1 SYRINGE (49281-726-88)

Linked data

RxNorm, label and prices

Use it

Look up 49281-726 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49281-726 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49281-726. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.